Small-cap Health Care company Canopy Growth has logged a 1.1% change today on a trading volume of 1,775,509. The average volume for the stock is 7,433,390.
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. Based in Smiths Falls, Canada the company has 3,151 full time employees and a market cap of $905,705,600.
The company is now trading -7.57% away from its average analyst target price of $1.98 per share. The 5 analysts following the stock have set target prices ranging from $1.0 to $3.32, and on average give Canopy Growth a rating of underperform.
Over the last year, CGC shares have gone down by -7726.0%, which represents a difference of -6355.0% when compared to the S&P 500. The stock's 52 week high is $8.64 per share and its 52 week low is $1.81. With its gross margins declining an average -67.2% over the last four years, Canopy Growth may not have a strong enough business to reverse this trend.
| Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-03-31 | 520,325 | 713,379 | -37.1 | -402.86 |
| 2021-03-31 | 546,649 | 479,689 | 12.25 | 254.09 |
| 2020-03-31 | 398,772 | 430,456 | -7.95 | -120.23 |
| 2019-03-31 | 226,341 | 137,411 | 39.29 | n/a |
